Skip to main content
PepStack

Epinephrine

Adrenal Hormones
AdrenalineEpiPenAdrenalin

Overview

Epinephrine, also known as adrenaline, is both an endogenous hormone and a synthetic compound. It is produced in the adrenal medulla, a part of the adrenal glands, and belongs to the catecholamine chemical class. As a hormone and neurotransmitter, epinephrine plays a crucial role in the body's fight-or-flight response. Researchers have extensively studied its effects on cardiovascular and respiratory systems, as well as its role in metabolic processes. Epinephrine is primarily involved in increasing heart rate, contracting blood vessels, and dilating air passages. It is a key focus in research areas such as anaphylaxis, cardiac arrest, and asthma management. The mechanism of action of epinephrine involves its interaction with adrenergic receptors, specifically alpha and beta receptors. Upon binding to these receptors, it activates a cascade of intracellular events, including the activation of adenylate cyclase and increased cyclic AMP levels, leading to physiological responses such as increased cardiac output and bronchodilation. Pharmacokinetically, epinephrine has a short half-life, with intravenous administration resulting in a half-life of approximately 2-3 minutes due to rapid metabolism by the liver and other tissues. Its bioavailability varies significantly with the route of administration, being poor when taken orally due to extensive first-pass metabolism. Clinically, epinephrine is used in emergency situations such as anaphylactic shock and cardiac arrest. It is available in various formulations, including auto-injectors like EpiPen. Regulatory agencies worldwide have approved its use, with specific guidelines for administration and storage.

Mechanism of Action

Epinephrine acts on both alpha and beta adrenergic receptors, triggering a biological cascade that includes the activation of adenylate cyclase and an increase in cyclic AMP levels. This leads to physiological effects such as increased heart rate, vasoconstriction, and bronchodilation.

Molecular Data

FormulaC9H13NO3
Molecular Weight183.2 g/mol
CAS Number51-43-4
PubChem CID5816

Half-Life & Pharmacokinetics

EndogenousCirculating half-life ~2-3 minutes
Intravenous~2-3 minutes
OralPoor bioavailability due to first-pass metabolism

Epinephrine's short half-life necessitates rapid administration in acute settings. Different formulations may affect absorption rates.

Storage

Temperature

Store at room temperature (15-30°C)

Light

Protect from light

Form

Aqueous solution: use within specified time after opening

Notes

Ensure auto-injectors are not expired and are stored in their original packaging.

Solubility

Epinephrine is soluble in water, which is relevant for its formulation in aqueous solutions for injection.

Legal Status

🇩🇪DE

Verschreibungspflichtig (prescription only); not listed under BtMG.

🇺🇸US

FDA approved for emergency use in anaphylaxis; prescription required.

🇦🇺AU

TGA Schedule 4 (prescription only medicine).

🇬🇧UK

Prescription only medicine (POM); regulated by MHRA.

Legal status information is provided for general reference only and may not reflect the most current regulatory changes. Always verify with official government sources before making any decisions.

8 Research Publications

Pharmacokinetics/pharmacodynamics of epinephrine after single and repeat administration of neffy, EpiPen, and manual intramuscular injection.

Human

The Journal of allergy and clinical immunology · 2023

Researchers observed that neffy, an intranasal epinephrine delivery device, provides an effective alternative to traditional injection methods for treating severe allergic reactions. The study found that neffy produced comparable or better responses than EpiPen and manual injections, making it a promising option for those hesitant to use injection devices.

  • Neffy showed a pharmacokinetic profile between EpiPen and manual injection.
  • Neffy resulted in more significant pharmacodynamic responses compared to EpiPen and manual injection.
  • Neffy is expected to be a safe and effective option for patients and caregivers.
PubMed

Who Needs Epinephrine? Anaphylaxis, Autoinjectors, and Parachutes.

Review

The journal of allergy and clinical immunology. In practice · 2023

Researchers observed that while epinephrine autoinjectors are crucial for treating anaphylaxis, there are uncertainties about when to use them and whether emergency services should be called afterward. They highlighted that a poor response to epinephrine may indicate a more severe reaction, and patients should not rely solely on autoinjectors for safety.

  • Epinephrine is the first-line treatment for anaphylaxis and is generally safe.
  • There is uncertainty about when to administer epinephrine and when to contact emergency services.
  • A poor response to epinephrine may indicate a need for urgent medical attention.
PubMed

Pharmacokinetic and pharmacodynamic comparison of epinephrine, administered intranasally and intramuscularly: An integrated analysis.

Human

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2023

Researchers found that intranasal epinephrine (neffy) can effectively increase blood pressure during severe allergic reactions, even though it reaches lower maximum levels in the bloodstream compared to manual intramuscular injections and autoinjectors. This suggests that intranasal delivery may be a viable alternative for treating anaphylaxis.

  • Intranasal epinephrine led to comparable increases in blood pressure despite lower maximum plasma concentrations.
  • Manual intramuscular injections and autoinjectors produced higher maximum concentrations of epinephrine.
  • Intranasal delivery may serve as an effective alternative for treating severe allergic reactions.
PubMed

Epinephrine (adrenaline) compared to selective beta-2-agonist in adults or children with acute asthma: a systematic review and meta-analysis.

Meta-Analysis

Thorax · 2022

Researchers found that while international guidelines generally advise against using epinephrine for acute asthma, some studies explored its effects compared to selective beta-2-agonists. The evidence from these studies was of low quality, indicating uncertainty about the effectiveness of epinephrine in treating acute asthma symptoms.

  • Epinephrine is not typically recommended for acute asthma unless linked to severe allergic reactions.
  • Only 38 out of 1140 studies met the criteria for inclusion in the analysis.
  • The overall quality of evidence regarding the use of epinephrine for asthma was low.
PubMed

Epinephrine in the Management of Anaphylaxis.

Human

The journal of allergy and clinical immunology. In practice · 2020

Researchers found that epinephrine is the most effective treatment for anaphylaxis and should be administered quickly to reduce serious health risks. They observed a need for better understanding of dosing and delivery methods to ensure all patients, regardless of size, can easily access and use epinephrine autoinjectors.

  • Epinephrine is the first-line treatment for anaphylaxis.
  • Prompt administration is crucial for minimizing health risks.
  • There is a need for improved access and usability of epinephrine autoinjectors for all patients.
PubMed

Epinephrine delivery via EpiPen

Human

Clinical and translational allergy · 2020

Researchers found that using an EpiPen for delivering epinephrine resulted in higher and faster absorption of the medication compared to traditional intramuscular syringes. This was consistent across individuals with varying skin-to-muscle distances, suggesting that EpiPens are effective even if the needle does not fully penetrate the muscle. Overall, the study indicates that EpiPens provide reliable delivery of epinephrine during anaphylactic emergencies.

  • EpiPen injections led to higher peak epinephrine levels compared to IM syringes.
  • EpiPen provided faster absorption of epinephrine within the first 30 minutes.
  • EpiPen delivery was effective across different skin-to-muscle distance groups.
PubMed

Epinephrine (adrenaline) in anaphylaxis.

Review

Chemical immunology and allergy · 2010

Researchers found that epinephrine is the most effective treatment for anaphylaxis and should be administered immediately for the best results. They observed that the recommended dose for adults is 0.3-0.5 mg injected into the thigh, and that new, easier-to-use epinephrine formulations are being developed for community use.

  • Epinephrine is the first choice for treating anaphylaxis.
  • Prompt injection is crucial to prevent fatalities.
  • New formulations of epinephrine are being created for easier administration.
PubMed

[The consequence of epinephrine (adrenaline) overdose].

Review

Medicina (Kaunas, Lithuania) · 2006

Researchers observed that epinephrine, a medication used for various medical emergencies, can cause serious side effects when overdosed, often due to mistakes in administration. Symptoms of an overdose include agitation, high blood pressure, rapid heart rate, and irregular heartbeats. The review highlights the causes, symptoms, treatment options, and outcomes associated with epinephrine overdose.

  • Epinephrine overdose is typically caused by administration errors.
  • Common symptoms include agitation, hypertension, and tachycardia.
  • The review discusses treatment strategies and prognosis for overdose cases.
PubMed

Track your hormone research in PepStack

Log cycles, set reminders and visualize serum levels.

This page is for informational and research purposes only. All information is based on published scientific literature. Nothing on this page constitutes medical advice or replaces consultation with a qualified healthcare professional.